{ "company_number": "SC538432", "name": "Rothes Pharma Limited", "url": "/company/SC538432", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2016-06-21", "dissolved_on": null, "sic_codes": [ { "code": "47730", "description": "Dispensing chemist in specialised stores", "section": "G", "section_name": "Wholesale and retail trade; repair of motor vehicles and motorcycles", "url": "/sic/47730" } ], "registered_address": { "id": 1421728, "url": "/address/1421728", "line1": "26-28 HIGH STREET", "line2": "ROTHES", "post_town": "ABERLOUR", "county": "", "country": "UNITED KINGDOM", "postcode": "AB38 7AU" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/SC538432", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2027-06-30", "last_made_up": "2025-09-30", "category": "TOTAL EXEMPTION FULL", "filings": [ { "url": "/company/SC538432/accounts/2025-09-30", "pdf_url": "/company/SC538432/accounts/2025-09-30.pdf", "made_up_date": "2025-09-30", "period_start": "2025-09-30", "period_end": "2025-09-30", "entity_name": "Rothes Pharma Limited", "dormant": false, "average_employees": "0.10", "tangible_fixed_assets": "88594.00", "debtors": "166463.00", "cash_bank_in_hand": "146087.00", "current_assets": "360953.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "24967.00", "total_assets_less_current_liabilities": "113561.00", "net_assets_liabilities": "79190.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2026.zip" }, { "url": "/company/SC538432/accounts/2024-09-30", "pdf_url": "/company/SC538432/accounts/2024-09-30.pdf", "made_up_date": "2024-09-30", "period_start": "2024-09-30", "period_end": "2024-09-30", "entity_name": "Rothes Pharma Limited", "dormant": false, "average_employees": "9.00", "tangible_fixed_assets": "116700.00", "debtors": "181090.00", "cash_bank_in_hand": "162912.00", "current_assets": "407823.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "74557.00", "total_assets_less_current_liabilities": "191257.00", "net_assets_liabilities": "141451.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-May2025.zip" }, { "url": "/company/SC538432/accounts/2023-09-30", "pdf_url": "/company/SC538432/accounts/2023-09-30.pdf", "made_up_date": "2023-09-30", "period_start": "2023-09-30", "period_end": "2023-09-30", "entity_name": "Rothes Pharma Limited", "dormant": false, "average_employees": "10.00", "tangible_fixed_assets": "146051.00", "debtors": "158812.00", "cash_bank_in_hand": "193476.00", "current_assets": "399465.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "149611.00", "total_assets_less_current_liabilities": "295662.00", "net_assets_liabilities": "220416.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2024.zip" }, { "url": "/company/SC538432/accounts/2022-09-30", "pdf_url": "/company/SC538432/accounts/2022-09-30.pdf", "made_up_date": "2022-09-30", "period_start": "2022-09-30", "period_end": "2022-09-30", "entity_name": "Rothes Pharma Limited", "dormant": false, "average_employees": "8.00", "tangible_fixed_assets": "117509.00", "debtors": "128628.00", "cash_bank_in_hand": "175886.00", "current_assets": "342014.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "121541.00", "total_assets_less_current_liabilities": "239050.00", "net_assets_liabilities": "185220.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2023.zip" }, { "url": "/company/SC538432/accounts/2021-09-30", "pdf_url": "/company/SC538432/accounts/2021-09-30.pdf", "made_up_date": "2021-09-30", "period_start": "2021-09-30", "period_end": "2021-09-30", "entity_name": "Rothes Pharma Limited", "dormant": false, "average_employees": "8.00", "tangible_fixed_assets": "239614.00", "debtors": "188297.00", "cash_bank_in_hand": "138440.00", "current_assets": "358357.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "150641.00", "total_assets_less_current_liabilities": "390255.00", "net_assets_liabilities": "320668.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-May2022.zip" }, { "url": "/company/SC538432/accounts/2020-09-30", "pdf_url": "/company/SC538432/accounts/2020-09-30.pdf", "made_up_date": "2020-09-30", "period_start": "2020-09-30", "period_end": "2020-09-30", "entity_name": "Rothes Pharma Limited", "dormant": false, "average_employees": "8.00", "tangible_fixed_assets": "263605.00", "debtors": "141265.00", "cash_bank_in_hand": "245655.00", "current_assets": "419848.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "157608.00", "total_assets_less_current_liabilities": "421213.00", "net_assets_liabilities": "279587.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2021.zip" }, { "url": "/company/SC538432/accounts/2019-09-30", "pdf_url": "/company/SC538432/accounts/2019-09-30.pdf", "made_up_date": "2019-09-30", "period_start": "2019-09-30", "period_end": "2019-09-30", "entity_name": "Rothes Pharma Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "260056.00", "debtors": "100423.00", "cash_bank_in_hand": "86475.00", "current_assets": "224269.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "32633.00", "total_assets_less_current_liabilities": "292689.00", "net_assets_liabilities": "152502.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2020.zip" }, { "url": "/company/SC538432/accounts/2018-09-30", "pdf_url": "/company/SC538432/accounts/2018-09-30.pdf", "made_up_date": "2018-09-30", "period_start": "2017-10-01", "period_end": "2018-09-30", "entity_name": "Rothes Pharma Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "200263.00", "debtors": "84224.00", "cash_bank_in_hand": "57118.00", "current_assets": "172067.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-9228.00", "total_assets_less_current_liabilities": "278785.00", "net_assets_liabilities": "119394.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "89379.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2019.zip" } ], "pdf_only_filings": [ { "made_up_date": "2017-09-30", "filing_date": "2018-03-27", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-full", "paper_filed": true, "pdf_url": "/company/SC538432/accounts/2017-09-30.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/SC538432/filing-history/MzIwMDk2NDAzN2FkaXF6a2N4/document?format=pdf&download=0" } ], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/SC538432/filing-history" }, "confirmation_statement": { "next_due": "2027-07-04", "last_made_up": "2026-06-20" }, "officers": [], "psc": [ { "name": "Mr Kevin Douglas Herbert", "kind": "individual-person-with-significant-control", "person_url": "/person/2688540", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-75-to-100-percent", "voting-rights-75-to-100-percent" ], "notified_on": "2016-06-21", "ceased_on": "2021-06-26", "nationality": "British", "country_of_residence": "Scotland", "source": "snapshot" }, { "name": "Rothes Pharma Holdings Limited", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": "/company/SC702564", "natures_of_control": [ "ownership-of-shares-75-to-100-percent", "voting-rights-75-to-100-percent", "right-to-appoint-and-remove-directors" ], "notified_on": "2021-06-26", "ceased_on": null, "nationality": "", "country_of_residence": "", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-29T21:34:17.920293+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }